Conclusion:
"Preliminary data demonstrate that an insulin-inhibiting diet is safe and feasible in selected patients with advanced cancer. The extent of ketosis, but not calorie deficit or weight loss, correlated with stable disease or partial remission. Further study is needed to assess insulin inhibition as complementary to
standard cytotoxic and endocrine therapies."
standard cytotoxic and endocrine therapies."
Targeting insulin inhibition as a metabolic therapy in advanced cancer: A pilot safety and feasibility dietary trial in 10 patients
Fine, Eugene J. et al.
Nutrition , Volume 28 , Issue 10 , 1028 - 1035
